AB0380 Results from a randomized, single-blind, single-dose, parallel-group study in healthy subjects demonstrating pharmacokinetic similarity between abp 710 and infliximab

Abstract

BackgroundABP 710 is being developed as a biosimilar with the same amino acid sequence as infliximab, an anti-tumor necrosis factor therapy. Analytical and functional comparisons between ABP 710 and infliximab...